logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Oliver Illini

karl landsteiner institute of lung research and pulmonary oncology
H指数:9
被引数:246

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Second-line therapy in extensive-stage small cell lung cancer: an unmet need highlighted by real-world evidence from the LALUCA registry

广泛期小细胞肺癌的二线治疗：LALUCA登记研究中的真实世界证据凸显了这一未满足的需求

Lung Cancer
IF4.4
2026-09-300
OA
Daniel Moser; Anna Lang-Stöberl; Hannah Fabikan; Julie Krainer-Jacobs; Oliver Illini; Leyla Ay; Nino Müser; Christoph Weinlinger; Vania Mikaela Rodriguez; Georg-Christian Funk; Marie-Kathrin Breyer; Robab Breyer-Kohansal; Arschang Valipour; Maximilian J. Hochmair
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort

曲妥珠单抗德鲁替康（Trastuzumab Deruxtecan）在HER2突变非小细胞肺癌患者中的全身及颅内疗效与安全性：来自TRACER/HERTras真实世界队列的证据

Journal of Thoracic Oncology
IF20.8
2026-02-240
OAAI
Oliver Illini; Anna-Carina Hund; Hans-Georg Kopp; Mor Moskovitz; Giannis Mountzios; Wolfgang M. Brueckl; Martin Früh; Marie-Elisabeth Leßmann; Petros Christopoulos; Albrecht Stenzinger; Michael Thomas; Roni Gillis; Nir Peled; Fabian Acker; Alfredo Addeo; Andriani Charpidou; Christian Grohé; Laetitia Mauti; Sacha I. Rothschild; Sabine Schmid
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

EGFR突变的非小细胞肺癌的小细胞转化: DLL3的表达和免疫检查点抑制剂或酪氨酸激酶抑制剂联合化疗的疗效

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-12-010
OAAI
Saalfeld, Felix Carl; Moeller, Johanna; Christopoulos, Petros; Wenzel, Carina; Rasokatf, Anna; Wangg, Xuejun Alice; Vathiotish, Ioannis; Koenigi, David; Illinij, Oliver; Grohe, Christian; Wiesweg, Marcel; Wesseler, Claas; Schubart, Christoph; Pelusi, Natalie; Rohde, Gernot; Overbeck, Tobias R.; Kirfel, Jutta; Alt, Juergen; Kauffmann-Guerrero, Diego; Griesingerv, Frank; Kulhavyw, Jonas; Allgaeuer, Michael; Klimovay, Anna; Schuetz, Maret; Aust, Daniela E.; Hochmairj, Maximilian J.; Rothschild, Sacha I.; Syrigos, Konstantinos N.; Veluswamy, Rajwanth; Michels, Sebastian; Stenzinger, Albrecht; Joehrens, Korinna; Wermke, Martin
Prognostic impact of targetable driver alterations in resected early-stage lung cancer

靶向驱动改变对切除的早期肺癌的预后影响

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-11-011
OAAI
Terbuch, Angelika; Konjic, Selma; Schlintl, Verena; Absenger, Gudrun; Jost, Philipp J.; Lindenmann, Joerg; Swatek, Paul; John, Nikolaus; John, Teresa; Wurm, Robert; Zacharias, Martin; Posch, Florian; Hochmair, Maximilian J.; Fabikan, Hannah; Weinlinger, Christoph; Illini, Oliver; Horvath, Lena; Gamerith, Gabriele; Wolf, Dominik; Augustin, Florian; Brcic, Luka
Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR plus NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Saalfeld, F. C.; Moeller, J.; Michels, S.; Grohe, C.; Wiesweg, M.; Schubart, C.; Alt, J.; Griesinger, F.; Kauffmann-Guerrero, D.; Kulhavy, J.; Overbeck, T. R.; Pelusi, N.; Rohde, G.; Wesseler, C.; Vathiotis, I.; Veluswamy, R.; Illini, O. M.; Rothschild, S. I.; Christopoulos, P.; Wermke, M.
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

卡马替尼在MET外显子14突变的非小细胞肺癌 (RECAP) 中的实际经验: 来自早期访问计划的回顾性分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-06-1317
OAAI
Illini, Oliver; Fabikan, Hannah; Swalduz, Aurelie; Vikstrom, Anders; Krenbek, Dagmar; Schumacher, Michael; Dudnik, Elizabeth; Studnicka, Michael; Ohman, Ronny; Wurm, Robert; Wannesson, Luciano; Peled, Nir; Kian, Waleed; Bar, Jair; Daher, Sameh; Addeo, Alfredo; Rotem, Ofer; Pall, Georg; Zer, Alona; Saad, Akram; Cufer, Tanja; Sorotsky, Hadas Gantz; Hashemi, Sayed M. S.; Mohorcic, Katja; Stoff, Ronen; Rovitsky, Yulia; Keren-Rosenberg, Shoshana; Winder, Thomas; Weinlinger, Christoph; Valipour, Arschang; Hochmair, Maximilian J.
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Selpercatinib治疗RET融合阳性非小细胞肺癌 (SIREN): 通过access计划治疗的患者的回顾性分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2021-06-1140
OAAI
Illini, Oliver; Hochmair, Maximilian Johannes; Fabikan, Hannah; Weinlinger, Christoph; Tufman, Amanda; Swalduz, Aurelie; Lamberg, Kristina; Hashemi, Sayed M. S.; Huemer, Florian; Vikstrom, Anders; Wermke, Martin; Absenger, Gudrun; Addeo, Alfredo; Banerji, Shantanu; Calles, Antonio; Clarke, Stephen; Di Maio, Massimo; Durand, Alice; Duruisseaux, Michael; Itchins, Malinda; Kaaranien, Okko-Sakari; Krenn, Florian; Laack, Eckart; de Langen, Adrianus Johannes; Mohorcic, Katja; Pall, Georg; Passaro, Antonio; Prager, Gerald; Rittmeyer, Achim; Rothenstein, Jeffrey; Schumacher, Michael; Woell, Ewald; Valipour, Arschang
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis

洛拉替尼在ALK和ROS1-Rearrangement-Positive NSCLC中的后续治疗: 一项回顾性、多中心分析

PHARMACEUTICALS
IF4.8
2020-11-0722
OAAI
Hochmair, Maximilian J.; Fabikan, Hannah; Illini, Oliver; Weinlinger, Christoph; Setinek, Ulrike; Krenbek, Dagmar; Prosch, Helmut; Rauter, Markus; Schumacher, Michael; Woell, Ewald; Wass, Romana; Brehm, Elmar; Absenger, Gudrun; Bundalo, Tatjana; Errhalt, Peter; Urban, Matthias; Valipour, Arschang

研究方向

暂未获取到该数据
M
Maximilian J. Hochmair
H 指数:47论文数:469被引数:2.7万
H
Hannah Fabikan
H 指数:10论文数:52被引数:329
C
Christoph Weinlinger
H 指数:8论文数:50被引数:256
A
Arschang Valipour
H 指数:39论文数:260被引数:5,688
A
Anna Sophie Lang-Stöberl
H 指数:5论文数:20被引数:240
D
Dagmar Krenbek
H 指数:3论文数:14被引数:45
G
Gudrun Absenger
H 指数:21论文数:73被引数:2,287
M
Martin Wermke
H 指数:43论文数:301被引数:8,130
L
Luka Brčić
H 指数:41论文数:326被引数:5,056
R
Robert Zeillinger
H 指数:60论文数:415被引数:1.1万